256 related articles for article (PubMed ID: 12874858)
1. Polyacrylamide gel electrophoresis followed by sodium dodecyl sulfate gradient polyacrylamide gel electrophoresis for the study of the dimer to monomer transition of human transthyretin.
Altland K; Winter P
Electrophoresis; 2003 Jul; 24(14):2265-71. PubMed ID: 12874858
[TBL] [Abstract][Full Text] [Related]
2. Genetic microheterogeneity of human transthyretin detected by IEF.
Altland K; Benson MD; Costello CE; Ferlini A; Hazenberg BP; Hund E; Kristen AV; Linke RP; Merlini G; Salvi F; Saraiva MJ; Singer R; Skinner M; Winter P
Electrophoresis; 2007 Jun; 28(12):2053-64. PubMed ID: 17503405
[TBL] [Abstract][Full Text] [Related]
3. Electrically neutral microheterogeneity of human plasma transthyretin (prealbumin) detected by isoelectric focusing in urea gradients.
Altland K; Winter P; Sauerborn MK
Electrophoresis; 1999 Jun; 20(7):1349-64. PubMed ID: 10424456
[TBL] [Abstract][Full Text] [Related]
4. Sulfite and base for the treatment of familial amyloidotic polyneuropathy: two additive approaches to stabilize the conformation of human amyloidogenic transthyretin.
Altland K; Winter P; Saraiva MJ; Suhr O
Neurogenetics; 2004 Feb; 5(1):61-7. PubMed ID: 14534839
[TBL] [Abstract][Full Text] [Related]
5. Cys10 mixed disulfides make transthyretin more amyloidogenic under mildly acidic conditions.
Zhang Q; Kelly JW
Biochemistry; 2003 Jul; 42(29):8756-61. PubMed ID: 12873136
[TBL] [Abstract][Full Text] [Related]
6. Transthyretin forms amyloid fibrils at physiological pH with ultrasonication.
Misumi Y; Ueda M; Fujimori H; Shinriki S; Meng W; Kim J; Saito S; Obayashi K; Uchino M; Ando Y
Amyloid; 2008 Dec; 15(4):234-9. PubMed ID: 19065294
[TBL] [Abstract][Full Text] [Related]
7. Biophysical analyses of the transthyretin variants, Tyr114His and Tyr116Ser, associated with familial amyloidotic polyneuropathy.
Shinohara Y; Mizuguchi M; Matsubara K; Takeuchi M; Matsuura A; Aoki T; Igarashi K; Nagadome H; Terada Y; Kawano K
Biochemistry; 2003 Dec; 42(51):15053-60. PubMed ID: 14690414
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of transthyretin amyloid fibril formation by 2,4-dinitrophenol through tetramer stabilization.
Raghu P; Reddy GB; Sivakumar B
Arch Biochem Biophys; 2002 Apr; 400(1):43-7. PubMed ID: 11913969
[TBL] [Abstract][Full Text] [Related]
9. Acidic pH-induced conformational changes in amyloidogenic mutant transthyretin.
Pasquato N; Berni R; Folli C; Alfieri B; Cendron L; Zanotti G
J Mol Biol; 2007 Feb; 366(3):711-9. PubMed ID: 17196219
[TBL] [Abstract][Full Text] [Related]
10. Cys-10 mixed disulfide modifications exacerbate transthyretin familial variant amyloidogenicity: a likely explanation for variable clinical expression of amyloidosis and the lack of pathology in C10S/V30M transgenic mice?
Zhang Q; Kelly JW
Biochemistry; 2005 Jun; 44(25):9079-85. PubMed ID: 15966731
[TBL] [Abstract][Full Text] [Related]
11. Characterization of cysteine and homocysteine bound to human serum transthyretin.
Hanyu N; Shimizu T; Yamauchi K; Okumura N; Hidaka H
Clin Chim Acta; 2009 May; 403(1-2):70-5. PubMed ID: 19361464
[TBL] [Abstract][Full Text] [Related]
12. Detailed structural analysis of amyloidogenic wild-type transthyretin using a novel purification strategy and mass spectrometry.
Kingsbury JS; Théberge R; Karbassi JA; Lim A; Costello CE; Connors LH
Anal Chem; 2007 Mar; 79(5):1990-8. PubMed ID: 17261023
[TBL] [Abstract][Full Text] [Related]
13. Kinetic stabilization of the native state by protein engineering: implications for inhibition of transthyretin amyloidogenesis.
Foss TR; Kelker MS; Wiseman RL; Wilson IA; Kelly JW
J Mol Biol; 2005 Apr; 347(4):841-54. PubMed ID: 15769474
[TBL] [Abstract][Full Text] [Related]
14. The pathway by which the tetrameric protein transthyretin dissociates.
Foss TR; Wiseman RL; Kelly JW
Biochemistry; 2005 Nov; 44(47):15525-33. PubMed ID: 16300401
[TBL] [Abstract][Full Text] [Related]
15. Transthyretin aggregation under partially denaturing conditions is a downhill polymerization.
Hurshman AR; White JT; Powers ET; Kelly JW
Biochemistry; 2004 Jun; 43(23):7365-81. PubMed ID: 15182180
[TBL] [Abstract][Full Text] [Related]
16. A New Folding Kinetic Mechanism for Human Transthyretin and the Influence of the Amyloidogenic V30M Mutation.
Jesus CS; Almeida ZL; Vaz DC; Faria TQ; Brito RM
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589730
[TBL] [Abstract][Full Text] [Related]
17. Intermolecular disulfide linkages are not required for transthyretin amyloid fibril formation in vitro.
McCutchen SL; Kelly JW
Biochem Biophys Res Commun; 1993 Dec; 197(2):415-21. PubMed ID: 8267575
[TBL] [Abstract][Full Text] [Related]
18. Cys114-linked dimers of transthyretin are compatible with amyloid formation.
Karlsson A; Olofsson A; Eneqvist T; Sauer-Eriksson AE
Biochemistry; 2005 Oct; 44(39):13063-70. PubMed ID: 16185074
[TBL] [Abstract][Full Text] [Related]
19. Stability and fibril formation properties of human and fish transthyretin, and of the Escherichia coli transthyretin-related protein.
Lundberg E; Olofsson A; Westermark GT; Sauer-Eriksson AE
FEBS J; 2009 Apr; 276(7):1999-2011. PubMed ID: 19250316
[TBL] [Abstract][Full Text] [Related]
20. A new method for purification of human plasma retinol-binding protein and transthyretin.
Raghu P; Ravinder P; Sivakumar B
Biotechnol Appl Biochem; 2003 Aug; 38(Pt 1):19-24. PubMed ID: 12593674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
